Possible Association between the Use of Proton Pump Inhibitors and H(2) Receptor Antagonists, and Esophageal Cancer: A Nested Case–Control Study Using a Korean National Health Screening Cohort

Although safety concerns regarding proton pump inhibitor (PPI)/H2-receptor antagonists (H2RA) in the incident esophageal cancer have been raised, the Asian-based report is unclear. We investigated the estimated likelihood of incident esophageal cancer—its mortality depending on prior history of PPI/...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Hyo Geun, Lee, Hong Kyu, Kang, Ho Suk, Lim, Hyun, Kim, Joo-Hee, Kim, Ji Hee, Kim, Nan Young, Cho, Seong-Jin, Nam, Eun Sook, Min, Kyueng-Whan, Kwon, Mi Jung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146181/
https://www.ncbi.nlm.nih.gov/pubmed/35631344
http://dx.doi.org/10.3390/ph15050517

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146181/
https://www.ncbi.nlm.nih.gov/pubmed/35631344
http://dx.doi.org/10.3390/ph15050517

Ejemplares similares